These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3947532)

  • 1. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
    Stark Y; Leibovici J
    Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.
    Leibovici J; Susskind-Brudner G; Wolman M
    J Natl Cancer Inst; 1980 Aug; 65(2):391-6. PubMed ID: 6931256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide.
    Michowitz M; Stark Y; Leibovici J
    Cancer Lett; 1984 Jul; 23(3):343-9. PubMed ID: 6744256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levan on the fate of experimental hematogenous metastases of Lewis lung carcinoma.
    Bubis JJ; Leibovici J; Miron E; Michowitz M; Wolman M
    Exp Mol Pathol; 1982 Jun; 36(3):287-96. PubMed ID: 7084430
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
    Leibovici J; Stark Y
    J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro.
    Leibovici J; Stark Y
    Chem Biol Interact; 1986 Nov; 60(2):191-200. PubMed ID: 3791487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.
    Leibovici J; Borit A; Sandbank U; Wolman M
    Br J Cancer; 1979 Oct; 40(4):597-607. PubMed ID: 497110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of Lewis lung carcinoma by tumor excision and levan.
    Leibovici J; Michowitz M; Shezen E; Wolman M; Sandbank U
    Oncology; 1981; 38(1):31-4. PubMed ID: 7443174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in cell permeability to a cytotoxic agent by the polysaccharide levan.
    Leibovici J; Stark Y
    Cell Mol Biol; 1985; 31(5):337-41. PubMed ID: 4084938
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent.
    Michowitz M; Kopel S; Hoenig S; Leibovici J
    J Surg Oncol; 1987 Apr; 34(4):268-71. PubMed ID: 3560964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory and stimulatory effects of levan on growth of B16 melanoma--possible mechanisms.
    Yavetz H; Davidai G; Leibovici J; Wolman M
    Cell Mol Biol; 1985; 31(5):343-7. PubMed ID: 4084939
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
    Leibovici J; Stark Y; Wolman M
    Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of levan on tumorigenicity of cells from different murine tumors.
    Stark Y; Leibovici J
    Cell Mol Biol; 1984; 30(5):425-30. PubMed ID: 6529736
    [No Abstract]   [Full Text] [Related]  

  • 14. Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers.
    Leibovici J; Hoenig S; Stark Y; Kopel S; Wolman M
    Exp Cell Biol; 1984; 52(4):219-24. PubMed ID: 6734889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the inhibitory effect of levan on experimental tumors.
    Leibovici J; Stark Y; Eldar T; Brudner G; Wolman M
    Recent Results Cancer Res; 1980; 75():173-9. PubMed ID: 7232830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.
    Siegal A; Kopel S; Leibovici J
    Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
    Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
    Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
    Leibovici J; Kopel S; Siegal A; Gal-Mor O
    Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Lewis lung tumor growth and metastasis by Ehrlich ascites tumor growing in the same host.
    Himmele JC; Rabenhorst B; Werner D
    J Cancer Res Clin Oncol; 1986; 111(2):160-5. PubMed ID: 3700461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of levan-activated macrophages on Lewis lung carcinoma cells.
    Leibovici J; Hoenig S; Pinchassov A
    Int J Immunopharmacol; 1986; 8(5):471-8. PubMed ID: 3759297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.